Identifying an optimal treatment for schizophrenia: A 2-year randomized controlled trial comparing integrated care to a high-quality routine treatment

International Journal of Psychiatry in Clinical Practice

Volumn 15, Issue 2, 2011, Pages 118-127

  Sungur, Mehmet ^a,e   Soygür, Haldun ^b   Güner, Perihan ^c   Üstün, Besti ^d   Çetin, Ilkten ^a   Falloon, Ian R ^e  

^a MARMARA UNIVERSITY   (Turkey)

^b Abdurrahman Yurtaslan AO Training and Research Hospital   (Turkey)

^c KOÇ UNIVERSITY   (Turkey)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e NONE   (Turkey)

Author keywords

cognitive behavioural therapy; integrated care; optimal treatment; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVIDENCE BASED MEDICINE; FEMALE; HEALTH PROGRAM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPTICAL CASE MANAGEMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; ROUTINE CASE MANAGEMENT; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 79955750873     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2011.554987     Document Type: Article

References (40)

1. Essock SM, Drake RE, Frank RG, McGuire TG. Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question. Schiz Bull 2003;29:115-23. (Pubitemid 36871062)
2. Gilbody S, Wahlbeck K, Adams C. Randomized controlled trials in schizophrenia: a critical perspective on the literature. Acta Psychiatr Scand 2003;105:243-51.
3. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. American Psychiatric Association; Steering Committee on Practice Guidelines Practice guideline for the treatment of patients with schizophrenia second edition. Am J Psychiatry 2004;161 (Suppl):1-56.
4. National Institute for Clinical Excellence. Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. London: NICE, 2004 Clinical Guideline 1.
5. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia. Initial results from the Schizophrenia Patient Outcomes Research Team PORT client survey. Schizo Bull 1998;24:11-20.
6. Falloon IRH, Optimal Treatment Project Collaborators. Optimal treatment for psychosis in an International Multisite Demonstration Project. Psychiatr Serv 1999;50:615-18. (Pubitemid 29217636)
7. Turkington D, Kingdon D, Weiden PJ. Cognitive behavioural therapy for schizophrenia. Am J Psychiatry 2006;163: 365-73.
8. Turkington D, Kingdon D, Chadwick P. Cognitive behavioural therapy for schizophrenia: filling the therapeutic vacuum. Br J Psychiatry 2003;183:98-9. (Pubitemid 36963132)
9. Rathod S, Kingdon D, Smith P, Turkington D. Insight into schizophrenia: the effects of cognitive behaviour therapy on the components of insight and association with sociodemographics- data on a previously published randomized controlled trial. Schizophr Res 2005;74:211-19. (Pubitemid 40255079)
10. Turkingdon D, Kingdon D, Turner T. Effectiveness of a brief cognitive behaviour therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002;180:523-7. (Pubitemid 34596803)
11. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34(3):523-37.
12. Jones C, Cormac I, Silveira da Mota, Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004;4:Art. No. CD000524. DOI: 10.1002/14651858.CD000524.pub2.
13. Falloon IRH, Optimal Treatment Project Collaborators. Integrated mental health care-a guidebook for consumers. Perugia: ARIETE, Optimal Treatment Project; 1997.
14. Falloon IRH, Graham-Hole V, Fadden G et al. Integrated Mental Health Care: A programme of training in clinical management of mental disorders using effective efficient intervention strategies within a multidisciplinary team. Perugia: ARIETE, Optimal Treatment Project; 1996.
15. Falloon IRH, Mizuno M, Murakami M, Roncone R, Unoka Z, Harangozo J, et al. Structured assessment of current mental state in clinical practice: An international study of the reliability and validity of the Current Psychiatric State Interview CPS-50. Acta Psychiatr Scand 2005;111:44-50.
16. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Department of Health Education and Welfare; 1976.
17. Rosser RM, Kind P. A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol 1997; 7:347-58.
18. Falloon IRH. Family management of schizophrenia: clinical social family and economic benefits. Baltimore, MD: Johns Hopkins University Press Monograph; 1985.
19. Phelan M, Slade M, Thornicraft G, Dunn G, Holloway F, Wykes T, et al. The Camberwell assessment of needs: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry 1995; 167:589-95. (Pubitemid 26197767)
20. Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388-98.
21. Rosenthal R. Parametric measures of effect size. In: Cooper HM, Hedges LV, editors. The handbook of research synthesis. New York: Russell Sage Foundation; 1994. p 236-8.
22. Thornicroft G, Tansella M. Components of a modern mental health service: a pragmatic balance of community and hospital care: overview of systematic evidence. Br J Psychiatry 2004;185:283-90. (Pubitemid 39331329)
23. Leichsenring F. Randomized controlled versus naturalistic studies: a new research agenda. Bull Menninger Clin 2004;68 (2):137-51. (Pubitemid 38924487)
24. Kerwin R. Connecting patient needs with treatment Management. Acta Psychiatr Scand 2009;119(438):32-8.
25. Marshall M, Gray A, Lockwood A, Green R. Case management for people with severe mental disorders. Cochrane Database Syst Rev 1998;2:Art. No. CD000050. DOI: 10.1002/14651858.CD000050.
26. Phillips SD, Burns BJ, Edgar ER, Mueser KT, Linkins KW, Rosenheck RA, et al. Moving assertive community treatment into standard practice. Psychiatr Serv 2001; 52(6):771-9. (Pubitemid 32577435)
27. Hogarty GE, Anderson CM, Reiss DJ, Sander J. Kornblith SJ, Greenwald, DP, et al. Family psycho-education social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia: I. One-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 1986;43:633-42. (Pubitemid 16094174)
28. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RF, et al. Family psychoeducation social skills training and maintenance chemotherapy in the aftercare of schizophrenia. II two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry 1991;48:340-7.
29. Hogarty GE, Kornblith SJ, Greenwald D, DiBarry AL, Cooley S, Ulrich RF, et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family. I: description of study and effects on relapse rates. Am J Psychiatry 1997;154:1504-13. (Pubitemid 27471342)
30. H ogarty GE, Greenwald D, Ulrich RF, Kornblith SJ, DiBarry AL, Cooley S, et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family. II: Effects on adjustment of patients. Am J Psychiatry 1997;154:1514-24. (Pubitemid 27471343)
31. Falloon IRH. Family interventions of mental disorders: effi-cacy and effectiveness. World Psychiatry 2003;2:20-8.
32. Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry 1997;54:453-63. (Pubitemid 27198207)
33. Mueser KT, Torrey WC, Lynde D. Implementing evidencebased practices for people with severe mental illness. Behav Mod 2003;27:387-411.
34. Falloon IRH, Montero I, Sungur M, Mastroeni A, Malm U, Economou M, et al. Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment. World Psychiatry 2004;3:104-9.
35. Malm U, Ivarsson B, Allebeck P, Falloon IR. Integrated care in schizophrenia: a 2-year randomized controlled study of two community-based treatment programs. Acta Psychiatr Scand 2003;107:415-23. (Pubitemid 36683416)
36. Falloon IRH, Roncone R, Giosue P, et al. The integration of innovative biomedical and psychosocial strategies into clinical practice. In: Kashima H, Falloon IRH, Mizuno M, Asai M, editors. Comprehensive treatment of schizophrenia. Berlin: Springer; 2002. p 146-61.
37. Lieberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatric Serv 2005;56: 735-42. (Pubitemid 40770970)
38. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 2005;353(12): 1209-23.
39. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000;250:274-85. (Pubitemid 32002381)
40. Wright J, Turkington D, Kingdon DG, Basko MR, Cognitive behaviour therapy for severe mental illness: an illustrated guide. Wahington, DC: American Psychiatric Press; 2009. p 1-28.